Dexcom received its first FDA approval in 2006.
5 reports, 1 independent
Updated Aug 1
Gone quiet
- Reports
- 5
- Developments
- 1
- Repetition
- 80%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Dexcom received its first FDA approval in 2006.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Dexcom
company that develops, manufactures and distributes continuous glucose monitoring systems
Nothing else this week.
Related events
- Arise is seeking FDA approval for a drug as of October 7, 2026.
- FDA approval boosts the Korean drug industry, driving market attention for companies like SamChunDang Pharm.
- Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.
- Generic medicine services are seeking approval for launch from the FDA.
Coverage
Newest first; wire copies grouped- StockStory3 Reasons We’re Fans of DexCom (DXCM) Over the last six months, DexCom’s shares have sunk to $80.25, producing a disappointing 9.9% loss - a stark contrast to the S&P 500’s 5.8% gain. This may have i
- StockStoryDexCom’s (NASDAQ:DXCM) Q2 Sales Beat Estimates Medical device company DexCom (NASDAQ:DXCM) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 15.2% year on year to $1.16 billion. The